Who benefits most from early salvage radiation therapy after prostatectomy?

Affiliations

¹ Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
² Department of Radiation Medicine and Applied Science, University of California San Diego School of Medicine, La Jolla, CA, USA.

Editorial

Sameer K Nath et al. Transl Androl Urol. 2018 Mar.

. 2018 Mar;7(Suppl 1):S124-S127.

doi: 10.21037/tau.2017.11.23.

¹ Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
² Department of Radiation Medicine and Applied Science, University of California San Diego School of Medicine, La Jolla, CA, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series.
Fossati N, Karnes RJ, Boorjian SA, Moschini M, Morlacco A, Bossi A, Seisen T, Cozzarini C, Fiorino C, Noris Chiorda B, Gandaglia G, Dell'Oglio P, Joniau S, Tosco L, Shariat S, Goldner G, Hinkelbein W, Bartkowiak D, Haustermans K, Tombal B, Montorsi F, Van Poppel H, Wiegel T, Briganti A. Fossati N, et al. Eur Urol. 2017 Jun;71(6):886-893. doi: 10.1016/j.eururo.2016.07.028. Epub 2016 Jul 30. Eur Urol. 2017. PMID: 27484843

1. Fossati N, Karnes RJ, Colicchia M, et al. Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy. Eur Urol 2017. 10.1016/j.eururo.2016.07.028 - DOI - PubMed
1. Raldow A, Hamstra DA, Kim S, et al. Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy. Oncology (Williston Park) 2010;24:692-700, 702. - PubMed
1. Bolla M, van Poppel H, Tombal B, et al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet 2012;380:2018-27. 10.1016/S0140-6736(12)61253-7 - DOI - PubMed
1. Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol 2009;181:956-62. 10.1016/j.juro.2008.11.032 - DOI - PMC - PubMed
1. Wiegel T, Bartkowiak D, Bottke D, et al. Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial. Eur Urol 2014;66:243-50. 10.1016/j.eururo.2014.03.011 - DOI - PubMed